Healthcare Equipment and Supplies
Company Overview of ZOLL Medical Corporation
ZOLL Medical Corporation develops, manufactures, and markets resuscitation devices, related data management and software solutions, and temperature management technology worldwide. The company provides technologies that help clinicians, EMS and fire professionals, and lay rescuers in treating victims needing resuscitation and critical care. It offers lifevest wearable defibrillators for various indications comprising heart attack, before or after bypass surgery, or stent placement; patients with cardiomyopathy or congestive heart failures; and patients awaiting an implantable defibrillator or after removal of an implantable device due to infection or other reasons, as well as AutoPulse, an a...
269 Mill Road
Chelmsford, MA 01824
Founded in 1980
Key Executives for ZOLL Medical Corporation
Chief Executive Officer and Executive Director
President of ZOLL Data Management Products
President of ZOLL Core Products
Chief Operating Officer of ZOLL LifeVest and President of ZOLL LifeVest
Compensation as of Fiscal Year 2014.
ZOLL Medical Corporation Key Developments
ZOLL®Medical Corporation's ResQCPR System Receives Premarket Approval from FDA
Mar 9 15
ZOLL®Medical Corporation announced that the company’s ResQCPR System has been granted premarket approval (PMA) by the U.S. Food and Drug Administration (FDA) to market and begin U.S. distribution of the CPR adjunct system. The technology, which has been shown to improve the likelihood of survival in adult patients with non-traumatic cardiac arrest, is expected to be commercially available in mid-2015. A pivotal study evaluating the ResQCPR System, known as the ResQTRIAL, which the FDA considered in its approval process, demonstrated a 49% increase in survival to one year in adult patients who experienced out-of-hospital cardiac arrest of presumed cardiac etiology, as compared to treatment with conventional manual CPR. If widely implemented, the ResQCPR System could save thousands of lives each year in the U.S. from out-of-hospital cardiac arrest alone, based on these study results. The ResQCPR System uses Intrathoracic Pressure Regulation (IPR), a proprietary, non-invasive therapy developed by Advanced Circulatory Systems Inc. of Roseville, Minn., which ZOLL acquired in January 2015. This innovative technology uses the body’s own mechanisms to enhance circulation without the use of pharmaceutical or other agents. The ResQCPR System is comprised of the ResQPOD® Impedance Threshold Device and the ResQPUMP® Active Compression-Decompression CPR Device, which work synergistically to improve perfusion.
ZOLL Medical Corporation Wins $39.85 Million Federal Contract Award
Sep 26 14
ZOLL Medical Corporation was awarded a $39,848,375 federal contract by the Defense Logistics Agency Troop Support, Philadelphia, for access to airworthy defibrillators inventory for the U.S. Army, U.S. Navy, U.S. Air Force, U.S. Marine Corps and federal civilian agencies.
Jersey City Medical Center Uses ZOLL Medical Corporation's Driver Behavior Modification Technology to Prevent Ambulance Crashes and Improve Safety for the Community
Nov 5 13
Jersey City Medical Center EMS announced that to mitigate safety risks, JCMS EMS has deployed on-board safety technology that modifies driver behavior and provides real-time feedback alerting the drivers of dangerous driving habits. The goal is to instill a culture of safety among staff and the community, reducing the likelihood of a crash. The Road Safety(R) system from ZOLL Medical Corporation--much like an electronic co-pilot--measures multiple inputs including speed, braking, and G Forces on turns. If a driver, for example, is applying brakes too harshly, taking turns too severely, or exceeding pre-determined speed limits, audible tones will alert the driver to take corrective action.
Similar Private Companies By Industry
Recent Private Companies Transactions